EP 1037883 A1 20000927 - NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
Title (en)
NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
Title (de)
NEUE HETEROCYCLISCH SUBSTITUIERTE $g(a)-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN
Title (fr)
NOUVEAUX DERIVES D'ACIDE $g(a)-HYDROXYCARBOXYLIQUE HETEROCYCLIQUEMENT SUBSTITUES, LEUR PRODUCTION ET LEUR UTILISATION COMME ANTAGONISTES DU RECEPTEUR DE L'ENDOTHELINE
Publication
Application
Priority
- DE 19750529 A 19971114
- EP 9807026 W 19981104
Abstract (en)
[origin: US6358983B1] The present invention relates to carboxylic acid derivatives of the formula Ithe substituents having the meanings explained in the description, preparation and use as endothelin receptor antagonists.
IPC 1-7
C07D 277/34; C07D 263/38; A61K 31/425; A61K 31/42; C07D 277/60; C07D 277/68
IPC 8 full level
A61K 31/41 (2006.01); A61K 31/415 (2006.01); A61K 31/4164 (2006.01); A61K 31/42 (2006.01); A61K 31/421 (2006.01); A61K 31/422 (2006.01); C07D 249/12 (2006.01); A61K 31/4245 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/433 (2006.01); A61P 9/04 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/06 (2006.01); A61P 13/08 (2006.01); A61P 13/12 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 231/20 (2006.01); C07D 233/70 (2006.01); C07D 261/12 (2006.01); C07D 263/38 (2006.01); C07D 271/06 (2006.01); C07D 271/10 (2006.01); C07D 273/01 (2006.01); C07D 275/02 (2006.01); C07D 275/03 (2006.01); C07D 277/20 (2006.01); C07D 277/32 (2006.01); C07D 277/34 (2006.01); C07D 277/60 (2006.01); C07D 277/68 (2006.01); C07D 285/00 (2006.01); C07D 285/08 (2006.01); C07D 285/12 (2006.01); C07D 291/04 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01)
CPC (source: EP US)
A61P 9/00 (2018.01 - EP); A61P 9/04 (2018.01 - EP); A61P 9/08 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 9/12 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 13/08 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 261/12 (2013.01 - EP US); C07D 263/38 (2013.01 - EP US); C07D 275/03 (2013.01 - EP US); C07D 277/34 (2013.01 - EP US); C07D 277/60 (2013.01 - EP US); C07D 277/68 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
US 6358983 B1 20020319; AR 017581 A1 20010912; AU 1487899 A 19990607; AU 752165 B2 20020905; BG 104400 A 20010131; BR 9814157 A 20001003; CA 2308746 A1 19990527; CN 1278805 A 20010103; CO 4990973 A1 20001226; DE 19750529 A1 19990520; EP 1037883 A1 20000927; HR P980591 A2 19990831; HU P0004341 A1 20011028; HU P0004341 A3 20011228; ID 24819 A 20000824; IL 135461 A0 20010520; JP 2001523671 A 20011127; KR 20010032083 A 20010416; NO 20002154 D0 20000427; NO 20002154 L 20000512; NZ 504289 A 20020301; PL 340756 A1 20010226; SK 4932000 A3 20010212; TR 200001365 T2 20000921; WO 9925701 A1 19990527; ZA 9810425 B 20000515
DOCDB simple family (application)
US 53038200 A 20000427; AR P980105651 A 19981109; AU 1487899 A 19981104; BG 10440000 A 20000504; BR 9814157 A 19981104; CA 2308746 A 19981104; CN 98811085 A 19981104; CO 98067231 A 19981113; DE 19750529 A 19971114; EP 9807026 W 19981104; EP 98958900 A 19981104; HR P980591 A 19981113; HU P0004341 A 19981104; ID 20000882 A 19981104; IL 13546198 A 19981104; JP 2000521084 A 19981104; KR 20007005207 A 20000513; NO 20002154 A 20000427; NZ 50428998 A 19981104; PL 34075698 A 19981104; SK 4932000 A 19981104; TR 200001365 T 19981104; ZA 9810425 A 19981113